World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
20739
World Ranking
15787
National Ranking
513

Pierre Cochat publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierre Cochat sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 485 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierre Cochat D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Cochat sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pierre Cochat is affiliated with Claude Bernard University Lyon 1 in France. Their research primarily focuses on medicine, with particular specialization in pulmonary and respiratory medicine, pediatrics, perinatology and child health, molecular biology, pathology and forensic medicine, and nephrology.

The scientist's work encompasses several interconnected fields of study and topics. Key topics of their research include kidney stones and urolithiasis treatments, pediatric urology and nephrology studies, porphyrin metabolism and disorders, biomedical research and pathophysiology, urological disorders and treatments, neonatal health and biochemistry, and pharmaceutical economics and policy.

Frequent coauthors working alongside Pierre Cochat include Justine Bacchetta, Georges Deschênes, Aurélia Bertholet-Thomas, Yaacov Frishberg, and Jaap W. Groothoff.

Active in publishing scientific articles, Pierre Cochat has authored or contributed extensively to several journals with recurrent appearances in:

  • Pediatric Nephrology
  • Journal of the American Society of Nephrology
  • Néphrologie & Thérapeutique
  • Kidney International
  • Kidney International Reports

Some recent papers by the scientist include:

  • Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1, 2021, New England Journal of Medicine
  • PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2, 2022, Kidney International
  • Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria, 2021, Kidney International
  • Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1, 2021, Clinical Journal of the American Society of Nephrology
  • Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children, 2021, Genetics in Medicine

Best Publications

  • Measurement of Bone Mineral Content of the Lumbar Spine by Dual Energy X-Ray Absorptiometry in Normal Children: Correlations with Growth Parameters

    Catherine Glastre;Pierre Braillon;Louis David;Pierre Cochat

  • Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

    Agnès Doreau;Alexandre Belot;Alexandre Belot;Jérémy Bastid;Jérémy Bastid;Benjamin Riche

  • Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities

    Martin Zenker;Thomas Aigner;Olaf Wendler;Tim Tralau

  • Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

    Oliver Gross;Christoph Licht;Hans J. Anders;Bernd Hoppe

  • ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption

    Shazia Ashraf;Heon Yung Gee;Stephanie Woerner;Stephanie Woerner;Letian X. Xie

  • Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment

    Pierre Cochat;Sally-Anne Hulton;Cécile Acquaviva;Christopher J. Danpure

  • European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care

    Daniel Abramowicz;Pierre Cochat;Frans H. J. Claas;Uwe Heemann

  • Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

    Sander F. Garrelfs;Yaacov Frishberg;Sally A. Hulton;Michael J. Koren

  • Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study.

    B Bader-Meunier;J B Armengaud;E Haddad;R Salomon

  • IgACE: A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria

    Rosanna Coppo;Licia Peruzzi;Alessandro Amore;Antonio Piccoli

  • Paraneoplastic glomerular diseases and malignancies.

    Justine Bacchetta;Laurent Juillard;Pierre Cochat;Jean-Pierre Droz

  • Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults

    Albane Brodin-Sartorius;Albane Brodin-Sartorius;Marie-Josèphe Tête;Marie-Josèphe Tête;Patrick Niaudet;Patrick Niaudet;Corinne Antignac;Corinne Antignac;Corinne Antignac

  • Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study

    Djalila Mekahli;Aurelia Liutkus;Bruno Ranchin;Anchalee Yu

  • A Cluster of Mutations in the UMOD Gene Causes Familial Juvenile Hyperuricemic Nephropathy with Abnormal Expression of Uromodulin

    Karin Dahan;Olivier Devuyst;Michèle Smaers;Didier Vertommen

  • Epidemiology of primary hyperoxaluria type 1

    P Cochat;A Deloraine;M Rotily;F Olive

  • Nephropathic cystinosis: an international consensus document

    Francesco Emma;Galina Nesterova;Craig Langman;Antoine Labbé

  • Mutations in the human laminin β2 (LAMB2) gene and the associated phenotypic spectrum

    Verena V. Matejas;Bernward B. Hinkes;Bernward B. Hinkes;Faisal F. Alkandari;Lihadh Al-Gazali

  • Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.

    Alexandre Belot;Paul R. Kasher;Eleanor W. Trotter;Anne Perrine Foray

  • Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

    W Zhao;V Elie;G Roussey;K Brochard

  • A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study

    R. Grenda;A. Watson;R. Trompeter;B. Tönshoff

Frequent Co-Authors

Corinne Antignac
Corinne Antignac Institut Imagine
Patrick Niaudet
Patrick Niaudet Necker-Enfants Malades Hospital
Chantal Loirat
Chantal Loirat Grenoble Alpes University
Rolando Cimaz
Rolando Cimaz University of Milan
Denis Fouque
Denis Fouque Hôpital Édouard-Herriot
Martin Zeier
Martin Zeier University Hospital Heidelberg
Wim Van Biesen
Wim Van Biesen Ghent University Hospital
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Cornelius F. Boerkoel
Cornelius F. Boerkoel University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine isn’t limited to becoming a doctor. There are numerous online degree options that open doors to roles in the medical field. For example, those interested in administration or support roles may consider enrollment in accredited medical billing and coding schools with financial aid, which can lead to vital positions in healthcare settings.

Nursing remains in high demand, and aspiring nurses may be interested in nursing schools that don't require teas or hesi. Skipping these entrance exams can make programs more accessible and less daunting for many students.

Those seeking a leadership role may want to look into accelerated healthcare programs online. These flexible degree options are ideal for working professionals or those aiming to move quickly into management.

Registered nurses looking to advance can also explore rn to np bridge programs, which streamline the path to becoming a nurse practitioner. No matter your background, a range of online healthcare degrees can help you find your niche in medicine.

Best Scientists Citing Pierre Cochat

Trending Scientists

Recently Published Articles